Why Humacyte, Inc.’s vascular tissue platform is gaining attention in high-risk dialysis populations
Why Humacyte, Inc.’s ATEV is gaining traction in dialysis care. Explore clinical data, risks, and what comes next in vascular access innovation.
Can Covalon Technologies convert IV contamination education into adoption of VALGuard and CovaClear?
Covalon Technologies is gaining momentum in vascular access and wound care. Read why its latest milestones could shape medtech growth next.